Skip to content

REVB

REVELATION BIOSCIENCES, INC.

NASDAQ · Healthcare · Biotechnology · US

$0.93
−2.06%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
0.37x
Price / sales
Price / cash flow
-0.40x

Enterprise value

Enterprise value
-$7.0M
EV / sales
EV / EBITDA
0.65x
EV / EBIT
0.62x
Market cap
$3.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026